Novartis expects to eliminate US tariff exposure by mid‑2026, CEO tells CNBC

Core Insights - Novartis CEO Vas Narasimhan expressed confidence that the company's agreement with the U.S. government, along with its expanding manufacturing operations in the country, will safeguard it against potential tariffs [1] Group 1 - The agreement with the U.S. government is expected to provide a protective measure for Novartis against tariffs [1] - Novartis is expanding its manufacturing footprint in the U.S., which is a strategic move to mitigate risks associated with tariffs [1]